leqembi alzheimer news - Search News

European Committee Takes a Second Look at Alzheimer's Drug

Euronews (English) on MSN · 13m

European regulators green light new Alzheimer's drug after first rejecting it

European regulators initially said in July that the drug's benefits did not outweigh its risks. View on euronews

Associated Press on MSN · 15h

European committee takes a second look at Alzheimer’s drug and now says it should be approved

A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting the drug.

Changing course, European regulators now say Alzheimer’s treatment Leqembi should be approved

Reversing an earlier decision, European regulators recommended that an Alzheimer’s therapy from Eisai and Biogen should be approved.

FiercePharma18h

EMA changes tune, endorses Eisai and Biogen's Leqembi in restricted Alzheimer's population

Upon reexamination, the European Medicines Agency has made a U-turn on Eisai and Biogen’s Alzheimer’s disease drug Leqembi. | ...

9h

Ticker: Biogen Alzheimer’s drug gets second look in EU; Ford takes $165M hit on slow recall

A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...

GlobalData on MSN14h

EMA rethinks stance, committee now recommends Leqembi for Alzheimer’s disease

Following a re-evaluation, the EMA has recommended Eisai and Biogen’s Alzheimer’s therapy Leqembi for a subgroup of patients.

devdiscourse17h

EU Backs Leqembi: A Breakthrough in Alzheimer's Treatment

The European Union's drugs regulator has recommended approval for Eisai and Biogen's Alzheimer's drug Leqembi. This marks a ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results